STEAP2 is known to have cupric reductase activity; HCC cell lines with STEAP2 knockdown showed a decrease in copper levels (Fig. 2c) whereas STEAP2 overexpression cells showed an increase in copper levels (Sup. This evidence concerns the gene STEAP2 and hepatocellular carcinoma.